Medical Diagnosis » O » Onychomycosis

Medical Diagnosis
Search
» A
» B
» C
» D
» E
» F
» G
» H
» I
» J
» K
» L
» M
» N
» O
» P
» Q
» R
» S
» T
» U
» V
» W
» Y
» Z
 

Onychomycosis

 
 

Onychomycosis


OVERVIEW:

Infection of nail by fungi (dermatophytes, Candida, molds).

System(s) affected: Skin/Exocrine
Genetics: N/A
Incidence/Prevalence in USA: 22-130 cases/1000 population
Predominant age:
• Dermatophytes common in adults; even molds in older adults
Predominant sex:
• Candidal: adult women

SIGNS AND SYMPTOMS:

• Dermatophytes: Commonly preceded by dermatophyte infection at another site; 80% involve toenails - especially hallux; simultaneous infection of finger and toe nails rare. Four clinical forms occur:
• Distal subungual onychomycosis
• Spreads from hyponychium to nailbed to nail-plate
• Subungual hyperkeratosis
• Subungual paronychia
• Onycholysis
• Nail dystrophy
• Discoloration: yellow-brown
• Bois vermoulu (worm-eaten wood)
• Onychomadesis
• Lateral onychomycosis (common)
• Yellowish discoloration lateral nail groove
• Onycholysis, proximal or distal
• Proximal onychomycosis (rare)
• Hands or feet
• Leukonychia: begins under posterior nail groove, spreading to nail plate and lunula
• White superficial onychomycosis (rare)
• Hallux preferentially affected
• Infection of upper part of nail-plate
• Opaque white spots on nail plate eventually merge to involve entire surface of the nail
• Candidal:
• Hands 70% - especially dominant hand
• Middle finger most common
• Pain mild, unless secondarily infected
• Pain increases on prolonged contact with water
• Primarily affects tissue surrounding nail
• Begins with cuticle detachment
• Dark yellowish to blackish-brown zone along lateral border of nail
• Secondary ungual changes - convex, irregular, striated nail-plate with dull rough surface
• Onycholysis, especially on hands
• Distal subungual onychomycosis may occur
• Primary involvement of the nail-plate uncommon (thin, crumbly, opaque, brownish nail-plate deformed by transverse grooves)
• Periungual edema/erythema may occur (club-shaped, bulbous fingertips)
• Superficial white onychomycosis - young children
• Molds
• More common over 60 years old
• More common in nails of hallux
• Resembles distal and lateral onychomycosis

CAUSES:

• Dermatophytes (invade normal keratin)
Trichophyton rubrum - most common
Trichophyton mentagrophytes var. interdigitale - 25% as common as T. rubrum (most common pathogen for white superficial onychomycosis)
Epidermophyton floccosum, T. violaceum, Microsporum species less common
• Candida
• 70% Candida albicans
C. parapsilosis, C. tropicalis, C. krusei (less common)
• Molds (invade altered keratin)
Scopulariopsis brevicaulis, Hendersonula toruloidea, Aspergillus species, Alternaria tenuis, Cephalosporium, Scytalidium hyalinium

RISK FACTORS:

• Dermatophytes
• Warmth, moisture, hyperhidrosis
• Tight fitting shoes, rubber shoes
• Peripheral vascular disease
• Depressed cell-mediated immunity
• Indirect contamination
• Candidal
• Direct contamination - ano-vulvar, perirectal pruritus
• Chemical or mechanical damage to cuticle
• Maceration or occlusion
• Contact with substances containing sugar
• Hyperhidrosis
• Chilblain
• Cold hands (Raynaud's phenomenon)
• Psoriatic onycholysis
• Diabetes mellitus
• Hyperparathyroidism
• Addison's disease
• Malnutrition
• Malabsorption
• Dyscrasias
• Malignancies
• Postoperative conditions
• Altered immune function
• Molds
• Soil contamination
• Peripheral vascular disease
• Overlapping toes
• Onychogryphosis (deforming overgrowth of nails resulting in hooked or curved state)

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS:

• Herpetic whitlow
• Eczema
• Pustular psoriasis
• Tumor
• Darier's disease
• Pityriasis rubra pilaris
• Trophic changes, peripheral vascular disease
• Endocrine disease
• Drugs; chemicals
• Trauma
• Alopecia areata
• Lichen planus
• Yellow-nail syndrome (icterus, carotenemia, lymphedema, amyloidosis)
• White acquired nail disease (trauma, acute infection, chronic disease, thallium or arsenic poisoning, hepatic cirrhosis, chronic albuminemia)
• Brown-black pigment (melanotic, hematoma)
• Green dyschromia (Pseudomonas aeruginosa)
• Connective tissue disorders: dermatomyositis, scleroderma, Reiter's

LABORATORY:

• KOH preparation: clip or file away some of nail-plate as needed, collect scales from stratum corneum of most proximal area (beneath nail or crumbling nail itself with 1 mm curette), 5% KOH + gentle heat, 100% sensitive if > 2 preps examined
• Cultures - negative in 30% (secondary to loss of dermatophyte viability; improved by immediate culture on Sabouraud's and CC media)
• Histologic examination of keratin, punch or scalpel biopsy - proximal lesions with PAS stain
• All are influenced by quality of sampling
• CD4 < 450

Drugs that may alter lab results: Discontinue all topical medication several days before obtaining sample
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS:

Pathogens within the nail keratin

SPECIAL TESTS:

N/A

IMAGING:

N/A

DIAGNOSTIC PROCEDURES:

N/A

TREATMENT

APPROPRIATE HEALTH CARE:

• Outpatient - unless secondary cellulitis/osteomyelitis

GENERAL MEASURES:

• Avoid factors that promote fungal growth (heat, moisture)
• Treat underlying disease risk factors
• Treat other fungal infections
• Treat secondary infections

SURGICAL MEASURES:

• Nail removal to remove infected keratin
• Mechanical: soften with occlusive dressing, detach from nailbed with tweezers or file with abrasive paper/grinding stone
• Chemical: protect peripheral tissue with adhesive strips, apply ointment of 30% salicylic acid, 40% urea or 50% potassium iodide under occlusive dressing
• Surgical avulsion: for involvement of a few nails

ACTIVITY:

Restrictions based on promoting factors, underlying disease or secondary infection

DIET:

No special diet

PATIENT EDUCATION:

N/A

MEDICATIONS

DRUG(S) OF CHOICE:

• Dermatophytes - local: Less effective than systemic, apply under occlusive dressing, may mix with keratinolytic chemicals
• Imidazoles: Clotrimazole (Lotrimin, Mycelex), miconazole (Monistat), butoconazole, tioconazole, econazole (Spectazole), ketoconazole (Nizoral), sulconazole (Exelderm), oxiconazole (Oxistat), terbinafine (Lamisil)
• Unsaturated fatty acid derivatives: Propionic acid, undecylenic acid; haloprogin (Halotex); tolnaftate (Tinactin)
• Amorolfine (Loceryl) 5% topical lacquer
• Dermatophytes - systemic:
• Fluconazole (Diflucan) 400 mg po weekly for 6 months (pulse therapy), overall better tolerated than ketoconazole; expensive; reserve for extreme cases (disseminated disease, immunocompromised)
• Itraconazole (Sporanox): 400 mg po qd for a week per month for 2 months for fingernails and 3-4 months for toenails (pulse therapy)
• Terbinafine (Lamisil) 250 mg po qd for 3 months
• Candida:
• Imidazole derivative
• If bacterial infection present, use antibacterial plus anti-Candidal, e.g., nystatin (Mycostatin), topical amphotericin B (Fungizone), itraconazole (Sporanox) 200 mg po qd for 3 months, or fluconazole 400 mg po weekly for 6 months (pulse therapy)
• Mold:
• 1% iodinated alcohol, Whitfield's ointment, silver nitrate, glutaraldehyde, imidazole derivatives, itraconazole

Contraindications:
• Griseofulvin: porphyria, hepatocellular failure, serious side effects (leukopenia, persistent anemia), pregnancy
• Ketoconazole: hepatocellular disease, pregnancy
• Fluconazole: hepatocellular failure, pregnancy
Precautions:
• Topical agents: use with caution on broken skin, vascular compromise, decreased sensation
• Griseofulvin: monitor for hepatic, renal, hematopoietic side effects; photo-sensitivity; lupus-like symptoms or exacerbation. Take with meals to enhance absorption.
• Ketoconazole: hepatotoxicity (may be severe or fatal), anaphylaxis may (rarely) occur with first dose, decreased testosterone levels
• Fluconazole: decrease dose in renal failure, hepatotoxicity
Significant possible interactions:
• Griseofulvin: warfarin, barbiturates, alcohol, oral contraceptives
• Ketoconazole: warfarin, rifampin, cyclosporine, phenytoin, terfenadine
• Fluconazole: phenytoin (Dilantin), cyclosporine, oral hypoglycemics, oral anticoagulants, rifampin, hydrochlorothiazide
• Itraconazole and ketoconazole require gastric acid for absorption - effectiveness reduced with antacids, H2 blockers, omeprazole, etc.

ALTERNATIVE DRUGS:

• Dermatophytes - local: ciclopirox (Loprox, Penlac), naftifine (Naftin), cationic surfactants, e.g., benzalkonium chloride (Cetylcide), cetrimide, cetylpyridinium chloride (Ony-Clear, Fungoid)], halogenated / chlorinated / iodinated derivatives [chloramine, tincture of iodine], dyes [malachite green, crystal violet], mercury derivatives [thimerosal], phenols, glutaraldehyde
• Dermatophytes - systemic: griseofulvin (Fulvicin, Gris-PEG, Grisactin) ultramicrosize, usual adult dose 250-500 mg bid with meals for 6-12 months

FOLLOW UP

PATIENT MONITORING:

• Topical agents: slow response expected; visits q 6-12 weeks
• Griseofulvin: CBC and liver function tests initially, then q 3 months
• Ketoconazole: liver function tests q 3 weeks for the first 3 months, then monthly
• Itraconazole and fluconazole - liver function tests at start and at 4 weeks
• Terbinafine - liver function and hematologic tests at start and at 4 weeks
• Treatment duration (months): fingernails 6-9s, toenails 9-12, great toenail 12-24

PREVENTION/AVOIDANCE:

• Keep affected area clean and dry
• Avoid rubber or other occlusive footwear
• Avoid tight or ill-fitting footwear
• Wear absorbent cotton socks - avoid wool or synthetic fibers
• Change clothing and towels frequently and launder in hot water

POSSIBLE COMPLICATIONS:

• Secondary infections with progression to cellulitis/osteomyelitis

EXPECTED COURSE AND PROGNOSIS:

• Relapse common; prognosis especially poor if one hand, 2 feet or multiple nails involved
• 20-40% of nails fail to respond
• 40-70% of patients show long term relapse

MISCELLANEOUS

ASSOCIATED CONDITIONS:

• Immunodeficiency or chronic metabolic disease

AGE-RELATED FACTORS:


Pediatric:
• Rare before puberty
• Candidal infection presents more commonly as superficial white onychomycosis
Geriatric:
• Mold onychomycosis more common
• Predisposing diseases more common
• Hepatic/renal reserve limited
• Decreased ability for topical self-treatment
Others: N/A

PREGNANCY:

Drug choices limited

SYNONYMS:

• Tinea unguium
• Ringworm of the nail

ICD-9-CM:

110.1 Dermatophytosis of nail
112.3 Candidiasis of skin and nails

(see images)




Want to discuss this term? Visit our forum or our chat room.

SEE ALSO (Enter the keywords below into our search box or click on the link):

Respiratory distress syndrome, adult


Google
  Web medfamily.org

 
 
 
 

Total Medical Terms: 23

« 1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  »
Rate this site!


COPYRIGHT © 2001 - 2004 Medical Diagnosis

Joint Partnership with
Care Earth | SGU Community | Solo Futbol | TUMS-Ped | Med Family | Med School Chat | Law School Chat

part of the School Chat Network. All Rights Reserved. Hosted by My Crazy Cheap Hosting.
MSC: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15. By viewing this website, you agree to our disclaimer.
Cheap Medical Books | Cheap USMLE Books | Cheap MCAT Books | Cheap Books | Cheap Store

We're still here, you rockin' with the best!
Best View with 1024x768 screen and IE 5.0
Disclaimer: Although the medFamily materials have been developed by physicians and health care provider it is designed for educational purposes only. The site is not engaged in rendering medical advice. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. It is solely for information and second opinion purposes. If you have or suspect you may have a health problem, you should consult your health care provider and use the information here as a cross references. The authors, editors, producers, sponsors, and contributors shall have no liability, obligation or responsibility to any person or entity for any loss, damage, or adverse consequence alleged to have happened directly or indirectly as a consequence of this material.